IL17A and neoplasm: We observed that the IL-17 signalling pathway and Th17-cell differentiation pathway were enriched in the upregulated and downregulated groups, respectively, which suggested an indispensable role of the immune and inflammatory systems in tumour development with the adenosine-RNA-modification-derived risk model (Figure 3H).